Product logins

Find logins to all Clarivate products below.


Heart Valve Devices | Market Insights | Japan | 2023

The global COVID-19 pandemic negatively impacted the Japanese heart valve device market to some extent. However, in the longer term, the market will be driven by positive results from THV device clinical trials, new product launches, and the rapid adoption of THV devices, resulting in moderate growth through 2031.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for heart valve devices in Japan from 2019 through 2031.

Related Medtech Insights Reports

Report
Sports Medicine Devices – Market Insights – Japan
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, improved surgeon training, and high levels of sports participation will…
Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…
Report
Trauma Devices – Market Insights – Japan
The Japanese trauma device market will experience marginal growth through 2034, primarily fueled by the adoption of innovative, premium-priced technologies. This upward trend is further supported…
Report
Large-Joint Reconstructive Implants – Market Insights – Japan
Growth in large-joint reconstructive procedure volumes is being driven by favorable demographic trends and increased demand for innovative technologies. However, market expansion is partly…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…